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ABSTRACT
We report a case of a child with meningoencephalitis of atypical 
etiology. The patient developed the disease after an infection in 
the upper airways with unfavorable evolution. The clinical recovery 
was only possible after the administration of adequate antibiotic 
therapy for the etiological agent. This case report describes a 
child with meningoencephalitis of atypical etiology. The patient 
developed the disease after an infection in the superior airways with 
negative evolution. The clinical recovery was possible only after the 
introduction of adequate antibiotic therapy for the etiological agent.
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RESUMO
Este relato de caso descreve uma criança com menignoencefalite 
de etiologia atípica. A paciente desenvolveu a doença após infecção 
de vias aéreas superiores, com evolução desfavorável. Houve 
recuperação clínica somente após introdução de antibioticoterapia 
adequada para o agente etiológico. 
Descritores: Mycoplasma pneumoniae; Meningoencefalite/complicações; 
Meningoencefalite/quimioterapia, Diagnóstico diferencial; Relatos de 
casos
INTRODUCTION
Meningoencephalitis constitutes an inflammatory process 
of the brain parenchyma and meninges. It is characterized 
by fever, convulsion, irritability, recurrent sleepiness, 
headache and vomiting(1). 
Many etiologic agents can cause the disease, 
usually vírus, mainly enterovirus and herpes simplex 
virus 1 and 2. Although, other agents should be 
considered, such as: atypical bacteria (more specifically 
mycoplasma pneumoniae) fungi, Rickettsia, protozoa 
based on host immune factors, symptoms and geographic 
location(1). 
CASE REPORT
A 5 years and 8 months old previously healthy school 
girl was referred to our hospital with fever lasting for 
four days, three days of daytime sleepiness, weakness 
in lower limbs, difficulty in deambulation and changes 
in static balance. There was a record of upper airway 
infection with a skin rash three weeks before symptoms 
begun. 
On admission the patient presented good general 
condition, sleepiness, Glasgow coma scale score = 15, 
isochoric and photo reagent pupils, without sings of 
menigeal involvement, fever (37, 8ºC), blood pressure 
107 x 45 mmHg, heart rate of 106 bpm, oxygen saturation, 
96% in room air. She presented postural imbalance, 
negative Romberg test, nasal index and index-index tests 
with tremor during movements, imbalance in the lower 
limbs when standing and preserved muscle strength. 
The patient was referred to the Pediatric Intensive Care 
Unit for clinical observation and stayed there for 2 days. 
Afterwards, she was transferred to the Pediatric ward 
where she stayed until discharge. 
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Additional tests were performed at the time of 
admission. The blood cell count showed leukocytosis 
without left shift (leukocytes 17,600/mm³, neutrophils 
80%, lymphocytes 15%, monocyte 3%); normal platelet 
count (357.000/mm³); C-reactive protein 35.6 mg/L; skull 
tomography without changes; cerebrospinal fluid (CSF) 
compatible with lymphocytic meningitis (leukocytes 
350/mm³, segmented14%, lymphocytes 58%, monocytes 
28%); serum protein 67 mg/dL, glucose 48 mg/dL, 
chloride 684 mEq/L, lactic acid 14.6 mg/dL; magnetic 
resonance showed unspecific signal changes in the pons 
(rhombencephalitis); electroencephalogram with basal 
activity slightly disorganized because of diffuse slowing 
and lack of epileptiform waves. Based on neurologic 
changes at physical examination and in additional tests, 
we diagnosed meningoencephalitis of probable viral 
etiology, initiating the treatment with aciclovir.
The patient’s follow up showed slight improvement 
in sleepiness, but the fever remained. After 5 days of 
hospital stay new tests were done, and there was partial 
improvement of cellularity and protein dosage in CSF 
(leukocytes 231/mm³, segmented 23%, lymphocytes 
39%, monocytes 32%, glucose 38 mg/dL, protein 
55 mg/dL), blood cell count had a slightly increase of 
leukocytosis (leukocytes 18,100/mm³, gram-negative 
rods 2%, neutrophils 82%, lymphocytes 13%, monocytes 
3% and platelets 407,000/mm³). 
We associated ceftriaxone and clarithromycin, this last 
one particularly because the the prior respiratory episode. 
We conducted serology tests for M. pneumoniae. On the 
10th admission day and after five days of antibiotic therapy 
there was significant improvement in the neurological 
sings and symptoms as well as on the fever curve. 
The serology for herpes virus, cytomegalovirus, 
enterovirus varicella-zoster and M. pneumoniae in the 
CSF were negative. But, serology for M. pneumoniae 
in the blood was positive (IgG 1: 1,726 and IgM 1: 
3.452 by the immunoenzymatic assay method). The 
meningoencephalitis was diagnosed as likely being 
caused by M. pneumoniae, for this reason we stopped 
the use of ceftriaxone and continued with clarithromycin 
and acyclovir to complete the treatment. The patient was 
discharge after 15 days of hospital stay, although her 
sleepiness remained. We decided to use corticotherapy 
with prednisone 2 mg/kg/day for 10 days, and gradual 
reduction of the dosage. An asymptomatic follow up, 
without neurological sequelae was observed. 
DISCUSSION 
M. pneumoniae is a commom cause of respiratory tract 
infections and is more common in school-age children 
and adolescents. The incubation period may vary 
between 1 and 3 weeks. Its transmission is documented 
only by symptomatic individuals. 
Infection may also occur in other sites than the 
lungs such as skin, heart, joints and nervous system by 
direct action, production of neurotoxins or autoimmune 
mechanisms. This latter mechanism is the more accepted 
specially because M. pneumoniae has in its cytoplasm 
immunogenic substances like glycoproteins(²,³). Some 
studies show that approximately 2.6 to 4.8% of patients 
affected by M. pneumoniae have clinical neurological 
manifestations such as encephalitis (30%), transverse 
myelitis (30%), meningitis (20%), problems in pairs 
of cranial nerves (20%), cerebellitis (14%), psychiatric 
changes (8%), and 67% present previous sings of airway 
infection(³,4).
The diagnosis of neurological infection by M. 
pneumoniae can be made by laboratory tests, being 
ELISA the serologic test the most commonly used. The 
chemocytology of the CSF show moderate pleocytosis 
of lymphomonocytes, high protein and normal glucose 
levels. 
The etiologic agent can be found in these sites in 
about 2% of cases(3,5).
 The antibiotic of choice to treat 
the pulmonary infection in children is a macrolide, 
however, there is no consensus regarding the central 
nervous system treatment. It is well know that 
such class of antibiotic does not properly penetrate 
the blood brain barrier. However, because of its 
bacteriostatic and immunomodulatory effect, and 
one of the possible physiopathological mechanism of 
the disease is immunologic, it would be a treatment 
option. In addition, the use of corticosteroids, 
adopted in this case, must be always considered as 
immunosuppression depending on the degree of 
neurologic involvement(6,7).
CONCLUSION
The infection by M. Pneumoniae is usually found in the 
pediatric age, therefore, in the differential diagnosis of 
neurologic problems, which do not have a fair response 
to an initial antibiotic therapy, this agent should 
considered as its cause. The appropriated identification 
of this atypical agent enables more specific and early 
treatment. 
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